We are currently researching into
Rheumatic Heart Disease
New Zealand and Australia have the shared and unenviable status as developed countries that still have high rates of rheumatic fever and rheumatic heart disease. Pasifika children are about 40 times more likely to be hospitalised for rheumatic fever and Maori children are about 20 times more likely than non-Maori/non-Pacific children. Cure Kids is currently working with world-leading researchers to develop a coordinated programme of innovative research that aims to help end rheumatic fever and rheumatic heart disease in New Zealand.
In Progress Research
Developing a vaccine for strep A infections
Data suggests that TeeVax has the potential to be an effective vaccine against most strains of Group A Strep. New Zealand has the highest rates of acute rheumatic fever (ARF) and serious Group A Strep (GAS) disease, which predominately affects Māori and Pacific Island children. Our rates of ARF, which is linked to GAS infection, rival those seen in developing…
Developing a new diagnostic test for rheumatic fever
Dr Nikki Moreland University of Auckland Rheumatic fever is an autoimmune disease that develops after a Group A Streptococcus infection (commonly known as a strep infection). Rheumatic fever is most common in children aged 5-15 years old. It is a major cause of health inequality in New Zealand, occurring at unacceptably high rates in Maori and Pacific children, as well…